Topiramate belongs to the new class of neuromodulators, which has carbonic anhydrase inhibitor activity and been associated with renal calculi. It has also been shown to cause renal potassium wasting; however, it is generally clinically insignificant. Here, we describe a case of refractory hypokalemia in a patient with severe comorbidities who was on topiramate for seizures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MJT.0b013e3182691cf5 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!